
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
Luckily for you, our mission at StockStory is to help you make money and avoid losses by sorting the winners from the losers. Keeping that in mind, here is one stock under $50 with huge potential and two best left ignored.
Share Price: $33.12
With a diverse portfolio of eight FDA-approved medications targeting neurological conditions, Supernus Pharmaceuticals (NASDAQ:SUPN) develops and markets treatments for central nervous system disorders including epilepsy, ADHD, Parkinson's disease, and migraine.
Why Do We Think SUPN Will Underperform?
Supernus Pharmaceuticals’s stock price of $33.12 implies a valuation ratio of 16.1x forward P/E. If you’re considering SUPN for your portfolio, see our FREE research report to learn more.
Share Price: $42.89
Tracing its roots back to 1856 when it first opened its doors in Norwich, New York, NBT Bancorp (NASDAQ:NBTB) is a community-oriented financial institution providing banking, wealth management, and insurance services to individuals and businesses across the northeastern United States.
Why Does NBTB Worry Us?
NBT Bancorp is trading at $42.89 per share, or 1.2x forward P/B. Read our free research report to see why you should think twice about including NBTB in your portfolio.
Share Price: $34.92
With a strategic focus on low-risk, government-backed lending programs, Merchants Bancorp (NASDAQCM:MBIN) is an Indiana-based bank holding company specializing in multi-family mortgage banking, mortgage warehousing, and traditional banking services.
Why Is MBIN a Top Pick?
At $34.92 per share, Merchants Bancorp trades at 0.8x forward P/B. Is now a good time to buy? Find out in our full research report, it’s free.
Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.
While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Aug-07 | |
| Aug-05 | |
| Aug-04 |
Supernus and Indivior merge to create scaled, CNS-focused entity
SUPN -5.98%
Pharmaceutical Technology
|
| Aug-03 | |
| Aug-03 | |
| Aug-03 | |
| Aug-03 | |
| Aug-03 | |
| Aug-03 | |
| Jul-22 | |
| Jul-14 | |
| May-27 | |
| May-06 | |
| May-05 | |
| May-05 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite